Rafael Amado's Net Worth
$4.26 Million
Who is Rafael Amado?
Rafael Amado has an estimated net worth of $4.26 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Adaptimmune Therapeutics PLC, Zai Lab Ltd, and Poseida Therapeutics, Inc..
SEC CIK
Rafael Amado's CIK is 0001662119
Past Insider Trading and Trends
2023 was Rafael Amado's most active year for acquiring shares with 6 total transactions. Rafael Amado's most active month to acquire stocks was the month of December. 2022 was Rafael Amado's most active year for disposing of shares, totalling 7 transactions. Rafael Amado's most active month to dispose stocks was the month of September. 2024 saw Rafael Amado paying a total of $85,716.90 for 250,624 shares, this is the most they've acquired in one year. In 2020 Rafael Amado cashed out on 26,290 shares for a total of $1,006,176.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39
EVP R&DRafael Amado owns 541,946 units of Common Stock which is worth $1,295,250.94. In the year 2022 Rafael Amado filed a total of 17 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.01% | 10.66K |
$11.83 | -$100,099.50 | 541.95K |
Oct 7
| |||
Form 4
| -1.66% | -8.97K |
$11.06 | -$99,201.33 | 531.29K |
Oct 3
| |||
Form 4
| -0.37% | -2.00K |
$11.97 | -$23,940.00 | 540.26K |
Scheduled
|
Aug 2
| ||
Form 4
| -0.37% | -2.00K |
$11.44 | -$22,880.00 | 542.26K |
Scheduled
|
Jul 5
| ||
Form 4
| -0.37% | -2.00K |
$11.18 | -$22,360.00 | 544.26K |
Scheduled
|
Jun 21
| ||
Form 4
| -2.06% | -11.50K |
$7.40 | -$85,091.95 | 546.26K |
May 19
| |||
Form 4
| +74.15% | 237.36K |
—
|
—
| 557.48K |
Mar 23
| |||
Form 4
| -1.59% | -5.17K |
$7.71 | -$39,847.82 | 320.12K |
Mar 15
| |||
Form 4
| -3.43% | -11.51K |
$24.35 | -$280,185.09 | 323.93K |
Oct 1
| |||
Form 4
| +148.65% | 200.53K |
—
|
—
| 335.44K |
May 18
| |||
Form 4
| +22.60% | 24.87K |
—
|
—
| 134.9K |
Mar 26
| |||
Form 4
| -2.48% | -2.80K |
$38.05 | -$106,470.62 | 110.03K |
Mar 15
| |||
Form 4
| -12.90% | -16.54K |
$39.40 | -$651,514.51 | 111.68K |
Scheduled
|
Oct 7
| ||
Form 4
| -7.07% | -9.75K |
$36.37 | -$354,661.71 | 128.22K |
Oct 1
| |||
Form 4
| +29.29% | 30.8K |
—
|
—
| 135.96K |
Mar 18
| |||
Form 4
|
∞
| 105.16K |
—
|
—
| 105.16K |
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.09
President, R&DRafael Amado owns 17,237 units of American Depositary Shares representing Ordinary Shares which is worth $18,788.33. In the year 2016 Rafael Amado filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.05% | -11.04K |
$2.06 | -$22,748.58 | 17.24K |
Aug 6
| |||
Form 4
| -37.84% | -3.03K |
$5.37 | -$16,258.54 | 4.97K |
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zai Lab Ltd (ZLAB) Snapshot price: $19.85
See RemarksRafael Amado owns 20,417 units of American Depositary Shares which is worth $405,277.45. In the year 2023 Rafael Amado acquired a total of 173,391 shares in Zai Lab Ltd at a cost of $85,716.90, Rafael also disposed a total of 26,974 shares of Zai Lab Ltd equalling to $638,205.99.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.24% | -3.12K |
$16.20 | -$50,463.00 | 20.42K |
Aug 12
| |||
Form 4
| +17.12% | 3.44K |
$15.79 | $55,123.20 | 23.53K |
Apr 3 - Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| -11.24% | -2.54K |
$18.86 | -$47,979.84 | 20.09K |
Mar 15
| |||
Form 4
|
∞
| 22.64K |
$26.30 | -$509,169.45 | 22.64K |
Dec 29 - Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
∞
| 126K |
—
|
—
| 126K |
Dec 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Poseida Therapeutics, Inc. (PSTX) Snapshot price: $2.74
InvestorRafael Amado owns 58,950 units of Common Stock which is worth $161,523.00. In the year 2023 Rafael Amado acquired a total of 58,950 shares in Poseida Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.00% | 19.65K |
—
|
—
| 58.95K |
Jun 17
| |||
Form 4
|
∞
| 39.3K |
—
|
—
| 39.3K |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||